[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Dyne Therapeutics, Inc. Common Stock (DYN)

Dyne Therapeutics' stock surges as Oppenheimer upgrades PT to $40, citing positive clinical data and FDA designations, despite ongoing valuation concerns.

About Dyne Therapeutics, Inc. Common Stock

Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders.
Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Dyne Therapeutics, Inc. Common Stock (DYN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
Dyne Therapeutics, Inc. Common Stock (DYN) trading volume is up XXXXXX% from the previous week.
Dyne Therapeutics, Inc. Common Stock (DYN) social dominance is up 1655.56% from the previous week.
Dyne Therapeutics, Inc. Common Stock (DYN) creators is up XXXXX% from the previous week.
Dyne Therapeutics, Inc. Common Stock (DYN) engagements is up XXXXXX% from the previous week.
Dyne Therapeutics, Inc. Common Stock (DYN) mentions is up XXXXX% from the previous week.
Dyne Therapeutics, Inc. Common Stock (DYN) posts created is up XXXXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock price is currently influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns, leading to a recent pullback after gains. Social media indicates mixed sentiment with analyst target raises and institutional interest.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: XXXX%

1-Year High: $XXXXX on 2024-12-17
1-Year Low: $XXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #630 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXXXX
X Month: XXX -XXXXX
X Months: XXX +161
X Year: XXX -XXX
1-Year High: XXXXX on 2025-09-15
1-Year Low: X on 2024-12-28

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +1
X Month: XX -X
X Months: XX +7
X Year: XX -X
1-Year High: XX on 2025-12-08
1-Year Low: XX on 2025-12-03

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +992%
X Month: XXXXXXX +46%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-12-06

Engagements by network (24h): Reddit: X X: XXXXX YouTube: X

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +23%
X Month: XXX -XX%
X Months: XXXXX +10%
X Year: XXXXX +6.30%
1-Year High: XXX on 2025-10-27
1-Year Low: X on 2025-09-14

Mentions by network (24h): Reddit: X X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +11%
X Month: XXX -XX%
X Months: XXXXX +124%
X Year: XXXXX +74%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-14

The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BioStocks	X	XXXXXX	X	XXXXX
@RNAiAnalyst	X	XXXXXX	X	XXX
@adamfeuerstein	X	XXXXXXX	X	XXX
@TENETTRADEGROUP	X	XXXXXX	X	XXX
@MarcJacksonLA	X	XXXXX	X	XXX
@Quantumup1	X	XXXXX	X	XXX
@Fredbenz0	X	XXXXX	X	XXX
@Biobeats99	X	XXX	X	XXX
@BuyTheUgly	X	XX	X	XXX
@seedytx19	XX	XXXXX	X	XXX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% +4%
X Year: XX% +9%
1-Year High: XXX% on 2025-10-18
1-Year Low: XX% on 2025-01-04

Most Supportive Themes:

Positive Clinical Data and FDA Designation: (40%) Dyne Therapeutics' ACHIEVE trial for DM1 and FDA breakthrough designations are driving positive sentiment.
Favorable Analyst Ratings: (30%) Analyst ratings and price targets, with a consensus of Strong Buy and potential upside, are supporting the stock.
Institutional Ownership: (30%) High institutional ownership and confidence from major funds are contributing to a positive outlook.

Most Critical Themes:

Valuation Concerns: (100%) Downgrades from some analysts and concerns about valuation are creating caution despite promising clinical data.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.015%
X Month: XXXXX% +0.066%
X Months: XXXXX% +0.052%
X Year: XXXXX% +0.047%
1-Year High: XXXXX% on 2025-04-29
1-Year Low: XXXXXX% on 2025-09-14

Market Dominance: XXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-24
1-Year Low: XXXXXXX% on 2025-03-14

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$5.90%
X Month: $XXXXXXXXXXXXX -$1.10%
X Months: $XXXXXXXXXXXXX +$70%
X Year: $XXXXXXXXXXXXX -$0.58%
1-Year High: $XXXXXXXXXXXXX on 2025-10-28
1-Year Low: $XXXXXXXXXXX on 2025-04-08

Top Dyne Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"🍚💕 Following this blogger (@AL__PEACE12) has been a game-changer for my profits I can't thank him enough. #stocktok $NBLXF #Restructuring 😪 $DYCQ #Asset Allocation 👚 $DYN #High Price 🚳 $DWTX #Moving Average Convergence Divergence 🍵 $SPOT"
X Link @CParbs6868 2025-12-11T22:31Z X followers, XX engagements

"Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares"
Reddit Link @Quantisnow 2025-12-11T21:33Z X followers, X engagements

"$DUOL -Jefferies raises Duolingo target to $XXX from $XXX Hold - $DVN -Morgan Stanley raises Devon Energy target to $XX from $XX Overweight - $DXCM -Citi raises DexCom target to $XX from $XX Buy - $DYN -Stifel raises Dyne Therapeutics target to $XX from $XX Buy -"
X Link @MarcJacksonLA 2025-12-11T20:32Z 7632 followers, XXX engagements

"$DYN Guys Don't miss the Target price for Next Week. 🎯🚀"
X Link @Daniel_Berrickk 2025-12-11T19:42Z XX followers, XX engagements